Stock listing
COLL Stock Price, News, Filings & Events — Collegium Pharmaceutical, Inc.
Selected listing: COLL · NASDAQ · USD · US
This page tracks Collegium Pharmaceutical, Inc.'s COLL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COLL:NASDAQ. COLL:NASDAQ is the stock-level entry point for investors researching Collegium Pharmaceutical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Collegium Pharmaceutical, Inc. is a public company traded under the ticker COLL in the American market. The company has a market capitalization of approximately $1.14 billion. Collegium focuses on developing and commercializing innovative products for the treatment of pain and other medical conditions.
- Ticker
- COLL:NASDAQ
- Asset type
- Stock
- Market cap
- $882.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Collegium Pharmaceutical, Inc. COLL:NASDAQ stock context
This page tracks Collegium Pharmaceutical, Inc.'s COLL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COLL:NASDAQ. COLL:NASDAQ is the stock-level entry point for investors researching Collegium Pharmaceutical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Collegium Pharmaceutical, Inc. is a public company traded under the ticker COLL in the American market. The company has a market capitalization of approximately $1.14 billion. Collegium focuses on developing and commercializing innovative products for the treatment of pain and other medical conditions.
Latest news from Collegium Pharmaceutical, Inc.
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln
July 20, 2026
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
July 20, 2026
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
May 27, 2026
Collegium Pharmaceutical, Inc. earnings calls
Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Collegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Collegium Pharmaceutical, Inc. (COLL) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Collegium Pharmaceutical, Inc. (COLL) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Collegium Pharmaceutical, Inc. (COLL) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. investor report
Review AI stock analysis and investor report context for COLL:NASDAQ.
Collegium Pharmaceutical, Inc. company profile
View the public company page for Collegium Pharmaceutical, Inc. on 6ix.
Collegium Pharmaceutical, Inc. news
Read company news and market updates connected to Collegium Pharmaceutical, Inc..
Collegium Pharmaceutical, Inc. investor events
Find investor webinars, events, and replay context for Collegium Pharmaceutical, Inc..
Alternate listings
354:GETTEX
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
A14SUV:LSX
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
A14SUV:LS
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
COLL:BOATS
US · USD
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
354:FWB
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
354:DUS
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
354:MUN
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
354:SWB
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.
354:TRADEGATE
DE · EUR
Alternate listing for Collegium Pharmaceutical, Inc.; the primary context on this page is COLL:NASDAQ.